Chiron Discussing Fluvirin Corrective Manufacturing Plan For Liverpool Plant
Executive Summary
Chiron expects to implement a "remediation plan" over the coming months for a Liverpool facility after meeting with British regulatory officials on the suspension of its Fluvirin manufacturing license
You may also be interested in...
FDA Regulatory Affairs Head Glavin Brings Counterterrorism, Food Experience
FDA's new Associate Commissioner for Regulatory Affairs Margaret Glavin brings a background in food safety and bioterrorism to the post
FDA Regulatory Affairs Head Glavin Brings Counterterrorism, Food Experience
FDA's new Associate Commissioner for Regulatory Affairs Margaret Glavin brings a background in food safety and bioterrorism to the post
Unused Flu Vaccine Would Be Purchased By HHS Under Draft “BioShield II”
The Centers for Disease Control & Prevention would purchase a percentage of unused influenza vaccine doses at the end of each flu season under a draft version of the "BioShield II" bill